Top Story

Higher CV risk with acarbose than metformin in type 2 diabetes

March 27, 2015
In patients with type 2 diabetes, an initial regimen of acarbose therapy was associated with a moderately higher risk for cardiovascular disease compared with metformin therapy, according to recent findings.

In the nationwide cohort study, Lee-Ming Chuang, MD, PhD, of Nationwide Taiwan University Hospital, and colleagues evaluated data from the Taiwan National Health Insurance Database. The database includes information on outpatient visits, hospital admissions, prescriptions, disease and deaths for 99% of the population of Taiwan.

In the Journals

Updated diabetes care guidelines for PCPs stress importance of individualized treatment

March 23, 2015
Recent updates to the American Diabetes Association’s Standards of Medical Care in Diabetes place an emphasis on individualizing and tailoring care to each…
In the Journals

Diabetes prevalence lower in patients with familial hypercholesterolemia than unaffected relatives

March 11, 2015
Patients with familial hypercholesterolemia had a lower prevalence of type 2 diabetes compared with relatives without familial hypercholesterolemia, according to a…
Gabriela Vazquez-Benitez In the Journals

Diabetes, CVD increase rates of CV events

February 27, 2015
Among adults with diabetes, paying extra attention to traditional cardiovascular risk factors could reduce the rates of cardiovascular events and mortality, according to…
CME
Obesity Consults: Volume 2, Number 4 Obesity and the Cardiovascular System

Obesity Consults: Volume 2, Number 4
Obesity and the Cardiovascular System

This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.

Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
In the Journals

Elevated blood glucose linked to early death, other events in patients with acute HF

January 8, 2015
Slight elevation in blood glucose was associated with early mortality, future diabetes and future hospitalization among patients with acute HF, even…

New trial to focus on patients with multiple chronic diseases

January 7, 2015
A new NIH-funded, multicenter, clinical trial will be the first to focus on the management of patients with chronic kidney disease, diabetes, and…
Frank M. Sacks In the Journals

Glycemic index did not affect CV risk factors, insulin resistance

December 16, 2014
Diets containing foods with low glycemic index of dietary carbohydrate did not help patients with obesity or overweight achieve better insulin…
Kamlesh Khunti In the Journals

Hypoglycemia increased risks for CV events, death in patients with diabetes on insulin

December 15, 2014
Insulin-treated patients with diabetes who experience hypoglycemia are also more likely to experience cardiovascular events and die from any cause…
In the Journals

Higher insulin dosage for type 2 diabetes may increase mortality risk

December 10, 2014
Patients with type 2 diabetes taking exogenous insulin could be at increased risk for death from all causes, major adverse cardiovascular events and…
Steven Grover In the Journals

Life expectancy, healthy years likely to diminish with obesity-related diabetes, CVD

December 4, 2014
Obesity could reduce life expectancy by up to 8 years and healthy years of life by up to 19 years due to the effects of type 2 diabetes and…
Philipp Blanke Meeting News Coverage

Mild CAD increased CV event risk in patients with diabetes

December 3, 2014
Patients with diabetes who have even mild coronary artery disease are as likely to experience a cardiovascular event as those with serious…
Joseph Muhlestein, MD Meeting News CoveragePerspective

FACTOR-64: CCTA screening for CAD failed to reduce 4-year events in diabetes patients

November 17, 2014
CHICAGO — Screening for CAD by coronary computed tomography angiography did not reduce the composite rate of all-cause mortality, nonfatal MI…
Mohammed Ali In the Journals

'Cascade-of-care' displays gaps in US diabetes diagnosis, treatment

November 17, 2014
Using a cascade model to visualize the gaps in awareness of diabetes diagnosis, engagement in care and treatment in the United States, researchers…
Meeting News Coverage

DCB shows promise in femoropopliteal arterial disease, diabetes

November 6, 2014
A drug-coated balloon was safe and effective at 12 months in patients with femoropopliteal arterial disease and diabetes, according to findings…
More Headlines »
morganatic-roan
morganatic-roan